化瘀消癥方联合非司酮治疗围绝经期子宫腺肌病的临床观察.pdfVIP

化瘀消癥方联合非司酮治疗围绝经期子宫腺肌病的临床观察.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
化瘀消癥方联合非司酮治疗围绝经期子宫腺肌病的临床观察

The clinical efficacy of treating menopause adenomyosis with the Circulation Xiaozheng combined with mifepristone Speciality: Gynecology of TCM Tutor: LvMei Author : DongSixia Abstract Objective: To observe the clinical efficacy of the circulation Xiaozheng side combined with mifepristone in treating confining postmenopausal adenomyosis, and to explore its mechanism of action. Method: 60 cases of perimenopausal adenomyosis patients are randomly divided into treatment group (30 cases, oral circulation Xiaozheng side and mifepristone) and the control group (30 cases, oral mifepristone). Observe the clinical symptoms and signs of the patients of two groups before and after the treatment, as well as the changes of hemoglobin, immunological parameters, blood rheology, and the female endocrine hormone of the patients of two groups. Results: The clinical efficacy of the treatment group, namely, the efficacy of Chinese medicine symptomatology is better than the control group, and the statistical result is significant difference (P0.05); treatment group is significant in the efficacy of narrow Palace, correct anemia, improve various laboratory parameters (P0.05); follow-up observation and treatment group are better than the control group in the induction of menopause and reduce the efficacy of the Palace of body stability, and the statistical result is significant(P0.05). Conclusion: The circulation Xiaozheng side combined with mifepristone can improve the clinical symptoms and signs, reduce the Palace, correct anemia, improve blood rheology and the female endocrine levels, induce menopause, and enhance immunity. It has preferable clinical efficacy in treating confining postmenopausal adenomyosis. Keywords: circulation Xiaozhe

您可能关注的文档

文档评论(0)

canggu808866 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档